Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: A single-center retrospective study

Transplant Infectious Disease

Volumn 14, Issue 1, 2012, Pages 1-8

  Theodoropoulos, N ^a   Lanternier, F ^b   Rassiwala, J ^a   Mcnatt, G ^c   Preczewski, L ^a   Demayo, E ^c   Stosor, V ^a   Ison, M G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Candidate screening; Interferon release assay; Mycobacterium tuberculosis; Organ transplantation; QuantiFERON

Indexed keywords

GAMMA INTERFERON; ISONIAZID; PYRIDOXINE; RIFAMPICIN; STEROID; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; ASSAY; CYTOKINE RELEASE; FEMALE; HUMAN; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; TRANSPLANTATION; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; TUBERCULIN TEST;

EID: 84857053614     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00666.x     Document Type: Article

References (20)

1. Subramanian A, Dorman S. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4): S57-S62.
2. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998; 27(5): 1266-1277.
3. Holty JE, Gould MK, Meinke L, Keeffe EB, Ruoss SJ. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009; 15(8): 894-906.
4. Aguado JM, Torre-Cisneros J, Fortun J, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48(9): 1276-1284.
5. Targeted tuberculin testing and treatment of latent tuberculosis Infection. American Thoracic Society. MMWR Recomm Rep 2000; 49(RR-6): 1-51.
6. Sester M, Sester U, Clauer P, et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004; 65(5): 1826-1834.
7. Mazurek M, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010; 59(RR-5): 1-25.
8. Sester M, Sotgiu G, Lange C, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011; 37(1): 100-111.
9. van Zyl-Smit RN, Pai M, Peprah K, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med 2009; 180(1): 49-58.
10. Piana F, Codecasa LR, Cavallerio P, et al. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J 2006; 28(1): 31-34.
11. Manuel O, Humar A, Preiksaitis J, et al. Comparison of Quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007; 7(12): 2797-2801.
12. Chung WK, Zheng ZL, Sung JY, et al. Validity of interferon-gamma-release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microbiol Infect 2010; 16(7): 960-965.
13. Fitzpatrick MA, Caicedo JC, Stosor V, Ison MG. Expanded infectious diseases screening program for Hispanic transplant candidates. Transpl Infect Dis 2010; 12(4): 336-341.
14. Jahng AW, Tran T, Bui L, Joyner JL. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period. Transplantation 2007; 83(12): 1557-1562.
15. Singh N, Wagener MM, Gayowski T. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis. Transplantation 2002; 74(6): 892-895.
16. Fontana R, Jafri S-MR. Diagnosis and management of latent tuberculosis identified by the Quantiferon assay in liver transplant patients. Am J Transplant 2010; 10(Suppl 4): 97 [abstract].
17. Benito N, Sued O, Moreno A, et al. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation 2002; 74(10): 1381-1386.
18. Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009; 48(12): 1657-1665.
19. Menzies D, Pai M, Comstock G.Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146(5): 340-354.
20. Kim SH, Lee SO, Park IA, et al. Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation. Transpl Infect Dis 2010; 12(2): 113-119.